Infusion of Convalescent Plasma is Associated with Clinical Improvement in Critically Ill Patients with COVID-19: A Pilot Study

ABSTRACT Background: The ideal treatment of coronavirus disease (COVID)-19 has yet to be defined, but convalescent plasma (CoPla) has been successfully employed. Objective: The objective of the study was to study the safety and outcomes of the administration of CoPla to individuals with severe COVID-19 in an academic medical center. Methods: Ten patients were prospectively treated with plasma from COVID-19 convalescent donors. Results: Over 8 days, the sequential organ failure assessment score dropped significantly in all patients, from 3 to 1.5 (p = 0.014); the Kirby index (PaO2/FiO2) score increased from 124 to 255, (p < 0.0001), body temperature decreased significantly from 38.1 to 36.9°C (p = 0.0058), and ferritin levels also dropped significantly from 1736.6 to 1061.8 ng/ml (p = 0.0001). Chest X-rays improved in 7/10 cases and in 6/10, computerized tomography scans also revealed improvement of the lung injury. Decreases in C-reactive protein and D-dimer levels were also observed. Three of five patients on mechanical ventilation support could be extubated, nine were transferred to conventional hospital floors, and six were sent home; two patients died. The administration of CoPla had no side effects and the 24-day overall survival was 77%. Conclusions: Although other treatments were also administered to the patients and as a result data are difficult to interpret, it seems that the addition of CoPla improved pulmonary function.

Saved in:
Bibliographic Details
Main Authors: Olivares-Gazca,Juan C., Priesca-Marín,Jose M., Ojeda-Laguna,Martín, Garces-Eisele,Javier, Soto-Olvera,Silvia, Palacios-Alonso,Abraham, Izquierdo-Vega,Judith, Chacon-Cano,Rómulo, Arizpe-Bravo,Daniel, López-Trujillo,Miguel A., Cantero-Fortiz,Yahveth, Fernandez-Lara,Danitza, Ruiz-Delgado,Guillermo J., Ruiz-Argüelles,Guillermo J.
Format: Digital revista
Language:English
Published: Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán 2020
Online Access:http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0034-83762020000300159
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0034-83762020000300159
record_format ojs
spelling oai:scielo:S0034-837620200003001592021-04-30Infusion of Convalescent Plasma is Associated with Clinical Improvement in Critically Ill Patients with COVID-19: A Pilot StudyOlivares-Gazca,Juan C.Priesca-Marín,Jose M.Ojeda-Laguna,MartínGarces-Eisele,JavierSoto-Olvera,SilviaPalacios-Alonso,AbrahamIzquierdo-Vega,JudithChacon-Cano,RómuloArizpe-Bravo,DanielLópez-Trujillo,Miguel A.Cantero-Fortiz,YahvethFernandez-Lara,DanitzaRuiz-Delgado,Guillermo J.Ruiz-Argüelles,Guillermo J. Convalescent plasma Coronavirus disease-19 Severe coronavirus disease-19 ABSTRACT Background: The ideal treatment of coronavirus disease (COVID)-19 has yet to be defined, but convalescent plasma (CoPla) has been successfully employed. Objective: The objective of the study was to study the safety and outcomes of the administration of CoPla to individuals with severe COVID-19 in an academic medical center. Methods: Ten patients were prospectively treated with plasma from COVID-19 convalescent donors. Results: Over 8 days, the sequential organ failure assessment score dropped significantly in all patients, from 3 to 1.5 (p = 0.014); the Kirby index (PaO2/FiO2) score increased from 124 to 255, (p < 0.0001), body temperature decreased significantly from 38.1 to 36.9°C (p = 0.0058), and ferritin levels also dropped significantly from 1736.6 to 1061.8 ng/ml (p = 0.0001). Chest X-rays improved in 7/10 cases and in 6/10, computerized tomography scans also revealed improvement of the lung injury. Decreases in C-reactive protein and D-dimer levels were also observed. Three of five patients on mechanical ventilation support could be extubated, nine were transferred to conventional hospital floors, and six were sent home; two patients died. The administration of CoPla had no side effects and the 24-day overall survival was 77%. Conclusions: Although other treatments were also administered to the patients and as a result data are difficult to interpret, it seems that the addition of CoPla improved pulmonary function.info:eu-repo/semantics/openAccessInstituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránRevista de investigación clínica v.72 n.3 20202020-06-01info:eu-repo/semantics/reporttext/htmlhttp://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0034-83762020000300159en10.24875/ric.20000237
institution SCIELO
collection OJS
country México
countrycode MX
component Revista
access En linea
databasecode rev-scielo-mx
tag revista
region America del Norte
libraryname SciELO
language English
format Digital
author Olivares-Gazca,Juan C.
Priesca-Marín,Jose M.
Ojeda-Laguna,Martín
Garces-Eisele,Javier
Soto-Olvera,Silvia
Palacios-Alonso,Abraham
Izquierdo-Vega,Judith
Chacon-Cano,Rómulo
Arizpe-Bravo,Daniel
López-Trujillo,Miguel A.
Cantero-Fortiz,Yahveth
Fernandez-Lara,Danitza
Ruiz-Delgado,Guillermo J.
Ruiz-Argüelles,Guillermo J.
spellingShingle Olivares-Gazca,Juan C.
Priesca-Marín,Jose M.
Ojeda-Laguna,Martín
Garces-Eisele,Javier
Soto-Olvera,Silvia
Palacios-Alonso,Abraham
Izquierdo-Vega,Judith
Chacon-Cano,Rómulo
Arizpe-Bravo,Daniel
López-Trujillo,Miguel A.
Cantero-Fortiz,Yahveth
Fernandez-Lara,Danitza
Ruiz-Delgado,Guillermo J.
Ruiz-Argüelles,Guillermo J.
Infusion of Convalescent Plasma is Associated with Clinical Improvement in Critically Ill Patients with COVID-19: A Pilot Study
author_facet Olivares-Gazca,Juan C.
Priesca-Marín,Jose M.
Ojeda-Laguna,Martín
Garces-Eisele,Javier
Soto-Olvera,Silvia
Palacios-Alonso,Abraham
Izquierdo-Vega,Judith
Chacon-Cano,Rómulo
Arizpe-Bravo,Daniel
López-Trujillo,Miguel A.
Cantero-Fortiz,Yahveth
Fernandez-Lara,Danitza
Ruiz-Delgado,Guillermo J.
Ruiz-Argüelles,Guillermo J.
author_sort Olivares-Gazca,Juan C.
title Infusion of Convalescent Plasma is Associated with Clinical Improvement in Critically Ill Patients with COVID-19: A Pilot Study
title_short Infusion of Convalescent Plasma is Associated with Clinical Improvement in Critically Ill Patients with COVID-19: A Pilot Study
title_full Infusion of Convalescent Plasma is Associated with Clinical Improvement in Critically Ill Patients with COVID-19: A Pilot Study
title_fullStr Infusion of Convalescent Plasma is Associated with Clinical Improvement in Critically Ill Patients with COVID-19: A Pilot Study
title_full_unstemmed Infusion of Convalescent Plasma is Associated with Clinical Improvement in Critically Ill Patients with COVID-19: A Pilot Study
title_sort infusion of convalescent plasma is associated with clinical improvement in critically ill patients with covid-19: a pilot study
description ABSTRACT Background: The ideal treatment of coronavirus disease (COVID)-19 has yet to be defined, but convalescent plasma (CoPla) has been successfully employed. Objective: The objective of the study was to study the safety and outcomes of the administration of CoPla to individuals with severe COVID-19 in an academic medical center. Methods: Ten patients were prospectively treated with plasma from COVID-19 convalescent donors. Results: Over 8 days, the sequential organ failure assessment score dropped significantly in all patients, from 3 to 1.5 (p = 0.014); the Kirby index (PaO2/FiO2) score increased from 124 to 255, (p < 0.0001), body temperature decreased significantly from 38.1 to 36.9°C (p = 0.0058), and ferritin levels also dropped significantly from 1736.6 to 1061.8 ng/ml (p = 0.0001). Chest X-rays improved in 7/10 cases and in 6/10, computerized tomography scans also revealed improvement of the lung injury. Decreases in C-reactive protein and D-dimer levels were also observed. Three of five patients on mechanical ventilation support could be extubated, nine were transferred to conventional hospital floors, and six were sent home; two patients died. The administration of CoPla had no side effects and the 24-day overall survival was 77%. Conclusions: Although other treatments were also administered to the patients and as a result data are difficult to interpret, it seems that the addition of CoPla improved pulmonary function.
publisher Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
publishDate 2020
url http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0034-83762020000300159
work_keys_str_mv AT olivaresgazcajuanc infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy
AT priescamarinjosem infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy
AT ojedalagunamartin infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy
AT garceseiselejavier infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy
AT sotoolverasilvia infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy
AT palaciosalonsoabraham infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy
AT izquierdovegajudith infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy
AT chaconcanoromulo infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy
AT arizpebravodaniel infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy
AT lopeztrujillomiguela infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy
AT canterofortizyahveth infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy
AT fernandezlaradanitza infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy
AT ruizdelgadoguillermoj infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy
AT ruizarguellesguillermoj infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy
_version_ 1756219783578124288